Apple’s Leadership Change, CICT’s $6.4 Billion Asset Swap, Keppel and SGX RegCo

From a historic changing of the guard at Apple (NASDAQ: AAPL) to a transformative $6.4 billion portfolio pivot by CapitaLand Integrated Commercial Trust (SGX: C38U), this week has been anything but quiet.

We dive into the strategic moves redefining industry leaders, including the latest divestments by Keppel Limited (SGX: BN4) and a regulatory shake-up by Singapore Exchange (SGX: S68) designed to sharpen corporate transparency and unlock shareholder value.

Apple announced on 21 April 2026 that chief executive officer Tim Cook will step down from the top role effective 1 September 2026, ending a nearly 15-year tenure that began when he succeeded the late Steve Jobs in 2011.

Cook will transition to executive chairman of the board of directors, where he will assist the company in engaging with policymakers globally.

John Ternus, Apple’s senior vice president of Hardware Engineering, has been named as his successor, also effective 1 September 2026.

Ternus, 50, joined Apple in 2001 and was promoted to his current senior vice president role in 2021, making him the youngest member of the executive team at the time.

The transition was unanimously approved by the board and follows what Apple described as a thoughtful, long-term succession planning process.

Ternus has spent virtually his entire career at Apple and has been closely involved in many of its most significant product launches over the past two decades.

Investors will now be watching closely to see whether he can sustain Apple’s trajectory during a period of intensifying competition in artificial intelligence and consumer hardware.

CapitaLand Integrated Commercial Trust (CICT), Asia’s largest real estate investment trust (REIT), announced a landmark asset swap this week, agreeing to divest Asia Square Tower 2 (AST2) to IOI Properties for S$2.476 billion and to acquire the freehold Paragon on Orchard Road for S$3.9 billion.

To partly fund the Paragon acquisition, CICT launched a placement exercise to raise no less than S$600 million.

The divestment of AST2 represents a 9.9% premium to the property’s market valuation of S$2.252 billion as at 31 December 2025, at an exit yield of 3%.

Paragon is being acquired at a higher net property income yield of 3.9%, making the transaction yield accretive.

On a pro forma basis, CICT’s distribution per unit (DPU) is projected to rise to S$0.1183 from the FY2025 DPU of S$0.1158, representing an accretion of 2.1%.

Chief executive Tan Choon Siang described Paragon as a rare, premier freehold integrated development in the heart of Orchard Road that strengthens the resilience and quality of CICT’s Singapore-focused portfolio.



Source link

Visited 1 times, 1 visit(s) today

Related Article

Applied Materials Sinks 17% in a Week After a Forecast-Free Investor Day: “Tremendous Confidence”

Applied Materials Sinks 17% in a Week After a Forecast-Free Investor Day: “Tremendous Confidence” ©@Kittipong Jirasukhanont from PhonlamaiPhoto’s Images via Canva, @Iulian Catalin’s Images via Canva Key Takeaways Applied Materials stock has declined 24% since October 12, including a 6.7% drop following its October 13 investor presentation. Management outlined ambitious 2030 profitability targets but declined

What Will a $10,000 Investment in Palantir Be Worth by 2030?

Palantir (NASDAQ: PLTR) investors have had a fairly rocky 2026. For most of the year, the stock was losing money. However, starting in August, Palantir reversed the decline and has now gained about 12% for the year. That is roughly in line with the gain for the S&P 500 (SNPINDEX: ^GSPC). However, if you survey

3 Reasons to sell NEOG and 1 stock to buy instead

3 Reasons to sell NEOG and 1 stock to buy instead Neogen’s 25.9% return over the past six months has outpaced the S&P 500 by 16.8%, and its stock price has climbed to $11.78 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

3 Oil Stocks With Earnings Growth Over 5%

Oil just hit a five month high as supply risks from the Middle East and attacks on key energy facilities push energy markets back into the spotlight. When crude prices get this much attention, the largest integrated producers and pipeline giants can draw fresh investor interest. This article walks through three leading global oil and

Memory Stocks Are Plummetting. Jensen Huang Says the Bears Have It Wrong.

The AI trade has looked awfully shaky over the last couple of weeks. CoreWeave, the neocloud company that may have more leveraged exposure to AI than any other company due to its massive debt burden, has plunged in recent weeks on fears over its rising debt yields. Missed AI’s “Act 1”? Act 2 Could Be

Hormel (HRL) Stock Looks Reasonably Priced As Earnings Stay Steady

Hormel Foods has seen its share price slide over the past few years, and that drop puts a spotlight on a simple question for investors who focus on fundamentals. Is the current valuation of Hormel stock still in line with the earnings power the business is producing today? Over the past 5 years, the share

Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own

Biotech stocks live and die on access to capital, so the Federal Reserve’s signal that interest rates may pause for now gives this high risk corner of the market some breathing room. Cheaper money can make it easier to fund drug pipelines and clinical trials, which matters if you are hunting for the next breakthrough.

Why AT&T Stock Plunged on Friday

Shares of AT&T (NYSE:T) fell 8% on Friday after a new report stoked investors’ fears of a potentially disruptive encroachment by Space Exploration Technologies (NASDAQ:SPCX) into the lucrative U.S. wireless market. Image source: Getty Images. Missed AI’s “Act 1”? Act 2 Could Be 14x Bigger. Most investors think they missed the AI boat because they

Kulicke and Soffa (KLIC): buy, sell, or hold post Q2 earnings?

Kulicke and Soffa (KLIC): buy, sell, or hold post Q2 earnings? Over the past six months, Kulicke and Soffa’s stock price fell to $72.89. Shareholders have lost 13.9% of their capital, which is disappointing considering the S&P 500 has climbed by 9.1%. This may have investors wondering how to approach the situation. Is now the

Why RingCentral Stock Is Up Today

Shares of RingCentral (NYSE:RNG) rose 5% on Friday after the communications software provider raised its full-year free cash flow forecast. Image source: Getty Images. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same

AT&T Stock Sinks on Subscriber and SpaceX Worries. Is the Stock a Buy on the Dip?

AT&T (T -7.96%) stock had been on a roll, more than doubling from July 2023 to a closing high of $28.10 on March 27, 2026. However, after a strong start to 2026, AT&T stock has since come under pressure from the potential threat of Space Exploration Technologies (SPCX +1.89%) entering the U.S. mobile market. While

The AI sell-off is crushing stocks of companies leading the data center build-out

Two of the AI building boom’s biggest suppliers just posted blowout quarters. Wall Street is dumping them anyway. Bloom Energy (BE), whose fuel cells generate power on-site at data centers, said Thursday that sales jumped 138% last quarter and raised its full-year outlook to roughly 122% growth. Comfort Systems (FIX), which installs the cooling and

Bloom Energy Stock Sinks Despite Record Revenue and a Stellar Outlook. Is It Time to Buy?

Bloom Energy (NYSE:BE) delivered another blowout quarter, smashing estimates and growing profits faster than sales. Yet, its stock plunged after earnings and was down more than 12% as of Friday noon. The company sells solid-oxide fuel cell servers that turn natural gas into electricity right at a customer’s site. Artificial intelligence (AI) data centers desperately

Moderna trims losses as investors digest melanoma vaccine trial data

Moderna (MRNA) trimmed losses Friday, rebounding from a sharp sell-off in the previous session, as investors digested data from a late-stage trial of its personalized melanoma vaccine. The stock opened lower but climbed into positive territory during the session, a day after plunging more than 17% on Thursday in its worst single-day performance since Aug.

0
Would love your thoughts, please comment.x
()
x